Invention Disclosure Form (IDF) FAQ’s
An Invention Disclosure Form must be fully executed with all signatures in order to be valid.
Please contact the Office of Technology Commercialization (OTC) at (330) 672-0701 with any questions concerning the process.
-
What is the information in the IDF used for? Does the submission of an invention disclosure lead to a patent application?
The Invention Disclosure Form is an internal KSU form used to provide a written record of your intellectual property. The information described herein enables OTC to establish a record of the date of conception of the invention for legal purposes.
The information will be used to:
- Evaluate the technology for commercialization potential
- Protect the intellectual property
- Identify potential licensees
- Comply with sponsor reporting requirements
Submission of an IDF does not ensure that a patent application will be filed. 51Թ reserves the right, in its sole discretion, to determine which inventions it will seek to protect. The University Patent and Copyright Board will periodically review all disclosures and determine whether to pursue protection of the invention.
-
Why is the relevant support information (contract/grant) important?
Under federal law, the University is required to report inventions created under sponsored research funded by the U.S. Government. Non-government sponsors may also have intellectual property clauses and obligations associated with sponsored research agreements with which OTC must comply.
Complete the Funding/Sponsorship Information section thoroughly and accurately so the University can comply with all governmental and contractual reporting requirements.
-
Title of the invention?
This should be a non-enabling title and need not be the same as the title of the publication related to the invention.
-
What are the responsibilities of the KSU contributors?
Individual contributors certify that they are faculty, employees, staff, or students of 51Թ; that each made a material contribution to the invention; and that each agrees to assign all right, title, and interest to KSU pursuant to Ohio Revised Code 3345.14.
A separate assignment form will be provided to all KSU contributors prior to filing a patent application.
Contributors also agree to assist in the filing of patent applications and in the commercialization of the technology.
-
What is the importance of % contribution of individual contributors and how does it relate to royalty income?
Royalty income shall be distributed in accordance with the KSU Distribution of License and Royalty Income Guidelines:
The percentage contribution determines each contributor’s share of royalty revenue. Revenue generated from commercialization of the invention will be distributed to contributors based on their percentage contributions.
If the percentage fields are left blank, any net royalty income will be divided equally among all KSU contributors to the invention.
The University will honor the revenue-sharing agreement among contributors unless contributors reach a different agreement or otherwise required by law.
See also:
-
Who is an inventor?
Listing an individual in the “Inventor” section of an Invention Disclosure Form (IDF) does not guarantee that the individual will ultimately be named as an inventor on a patent application filed with the USPTO. Inventorship is a legal determination governed by U.S. patent law and is made in consultation with patent counsel during the prosecution process. Under U.S. patent law, an inventor is someone who contributed to the conception of at least one claimed element of the invention. Accurate determination of inventorship is critical, as improper inventorship can jeopardize the validity and enforceability of a patent. Further, inventorship is distinct from authorship on a publication. Being listed as an author, or being involved in research related to the invention, does not necessarily qualify an individual as an inventor.
-
Should visiting scientists or collaborators at other institutions be listed as inventors?
All non-KSU individuals who may have contributed to the ideas leading to a discovery should be identified as inventors with 0% KSU Contribution in the KSU Contributors section of the IDF.
The University reserves the right to separately reach agreement concerning revenue sharing with any non-KSU contributor determined to have an ownership interest.
-
How detailed should the description of the invention be?
The description should be as detailed as possible. Without adequate information, OTC cannot perform a complete evaluation of the invention’s licensing potential or obtain an accurate legal opinion regarding patentability.
For inventions supported by government sponsorship, the disclosure must contain sufficient technical detail to convey a clear understanding—based on what is known at the time of disclosure—of the nature, purpose, operation, and physical, chemical, biological, or electrical characteristics of the invention.
-
Why are the dates of conception and disclosure important?
On March 16, 2013, the U.S. patent system switched to a “first-inventor-to-file” system.
Dates of disclosure are important because, in the United States, inventors generally have one year from the date of public disclosure to file a patent application. Once one year has passed from the public disclosure date, patent rights may be lost.
Most foreign countries have an “absolute novelty” requirement, meaning patent rights may be lost immediately upon public disclosure of the invention.
Although the University does not frequently pursue foreign patent protection due to the associated costs, inventors are strongly encouraged to submit an invention disclosure to OTC well before any public disclosure so that foreign filing options remain available for potential licensees.
-
What is considered a public disclosure of an invention?
Almost any disclosure made without an obligation of confidentiality may constitute public disclosure.
Examples include, but are not limited to:
- Journal articles
- Conference abstracts or presentations
- Online publications or website postings
- Dissertations indexed through the library
- Oral discussions describing the invention in sufficient detail for someone else to make or use it
- Selling or offering for sale a prototype of the invention
-
Should faculty and students refrain from publishing a paper or submitting an abstract/making an oral presentation of an invention before OTC has filed a patent application?
The one-year grace period under U.S. patent law may permit a later U.S. patent filing. However, inventors should disclose inventions to OTC well before any public disclosure in order to preserve potential foreign patent rights.
-
If the invention is disclosed through a publication or oral presentation before OTC files a patent application, are patent rights lost?
Public disclosure prior to filing may eliminate foreign patent rights immediately.
In the United States, inventors generally have one year from the date of first public disclosure or publication to file a patent application.